United States 113th Congress Status: Enacted 1 R cosponsors

HR 4771 — Designer Anabolic Steroid Control Act of 2014

Last action — Became Public Law No: 113-260.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. ✓
    Passed House
  4. ✓
    Passed Senate
  5. ✓
    To Executive
  6. 6
    Enacted

This bill has been enacted into law. Introduced May 29, 2014. Enacted.

Summary

Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to add specified substances to the list of those included within the definition of "anabolic steroid." Provides that a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed and that is derived from, or has a chemical structure substantially similar to, an anabolic steroid that is listed, shall be considered to be an anabolic steroid for purposes of such Act if it: (1) has been created or manufactured with the intent of producing a substance that either promotes muscle growth or otherwise causes a pharmacological effect similar to that of testosterone; or (2) has been, or is intended to be, promoted in any manner suggesting that consuming it will promote any pharmacological effect similar to that of testosterone. Prohibits a substance from being considered to be a drug or hormonal substance for purposes of such Act if it is: (1) an herb or other botanical, a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical, or a combination of two or more such substances; or (2) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act and is not anabolic or androgenic. Requires any person claiming the benefit of such an exception to bear the burden of providing the appropriate evidence. Authorizes the Attorney General to issue an order adding a drug or other substance to the definition of "anabolic steroid" upon finding that: (1) the substance satisfies the criteria for being considered an anabolic steroid, and (2) such addition will assist in preventing abuse or misuse of the substance. Prohibits importing, exporting, manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC). Prescribes penalties. Sets forth an exemption from such IUPAC nomenclature requirement if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act, as described in this Act. Authorizes the Attorney General to: (1) collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled, and (2) publish a list of products containing an anabolic steroid that are not properly labeled.

Bill Text

We don't have the full text on file for this bill yet.

Read HR 4771 on the official United States source →

Action History

  1. Became Public Law No: 113-260.

  2. Signed by President.

  3. Presented to President.

  4. Message on Senate action sent to the House.

  5. Passed Senate without amendment by Unanimous Consent.

  6. Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S6696)

  7. Received in the Senate and Read twice and referred to the Committee on the Judiciary.

  8. Motion to reconsider laid on the table Agreed to without objection.

  9. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7459-7460)

  10. DEBATE - The House proceeded with forty minutes of debate on H.R. 4771.

  11. Considered under suspension of the rules. (consideration: CR H7459-7461)

  12. Mr. Pitts moved to suspend the rules and pass the bill, as amended.

  13. Placed on the Union Calendar, Calendar No. 434.

  14. Reported (Amended) by the Committee on Judiciary. H. Rept. 113-587, Part II.

  15. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-587, Part I.

  16. Ordered to be Reported (Amended) by Voice Vote.

  17. Committee Consideration and Mark-up Session Held.

  18. Subcommittee on Crime, Terrorism, Homeland Security, and Investigations Discharged.

  19. Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

  20. Ordered to be Reported (Amended) by Voice Vote.

  21. Committee Consideration and Mark-up Session Held.

  22. Committee Consideration and Mark-up Session Held.

  23. Forwarded by Subcommittee to Full Committee by Voice Vote .

  24. Subcommittee Consideration and Mark-up Session Held.

  25. Referred to the Subcommittee on Health.

  26. Referred to House Judiciary

  27. Referred to House Energy and Commerce

  28. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare labor
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 4771 do?
Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to add specified substances to the list of those included within the definition of "anabolic steroid." Provides that a drug or hormonal substance (other than estrogens, progestins, corticosteroids, and dehydroepiandrosterone) that is not listed and that is derived from, or has a chemical structure substantially similar to, an anabolic steroid that is listed, shall be considered to be an anabolic steroid for purposes of such Act if it: (1) has been created or manufactured with the intent of producing a substance that either promotes muscle growth or otherwise causes a pharmacological effect similar to that of testosterone; or (2) has been, or is intended to be, promoted in any manner suggesting that consuming it will promote any pharmacological effect similar to that of testosterone. Prohibits a substance from being considered to be a drug or hormonal substance for purposes of such Act if it is: (1) an herb or other botanical, a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical, or a combination of two or more such substances; or (2) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act and is not anabolic or androgenic. Requires any person claiming the benefit of such an exception to bear the burden of providing the appropriate evidence. Authorizes the Attorney General to issue an order adding a drug or other substance to the definition of "anabolic steroid" upon finding that: (1) the substance satisfies the criteria for being considered an anabolic steroid, and (2) such addition will assist in preventing abuse or misuse of the substance. Prohibits importing, exporting, manufacturing, distributing, dispensing, or possessing with intent to manufacture, distribute, or dispense any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry (IUPAC). Prescribes penalties. Sets forth an exemption from such IUPAC nomenclature requirement if such product is labeled in the manner required under the Federal Food, Drug, and Cosmetic Act, as described in this Act. Authorizes the Attorney General to: (1) collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled, and (2) publish a list of products containing an anabolic steroid that are not properly labeled.
Who sponsors HR 4771?
HR 4771 is sponsored by Joseph Pitts (R).
What is the current status of HR 4771?
This bill has been enacted into law. Introduced May 29, 2014. Enacted.
Where can I track HR 4771?
Track HR 4771 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 4771

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 4771

Last checked for changes about 19 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →